PMC:7784786 / 9459-9573 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7784786","sourcedb":"PMC","sourceid":"7784786","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7784786","text":"IL-6 levels were evaluated before itolizumab administration and after 2, 4 and 7 days of the first administration.","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"306","span":{"begin":0,"end":4},"obj":"Gene"},{"id":"329","span":{"begin":34,"end":44},"obj":"Chemical"}],"attributes":[{"id":"A306","pred":"tao:has_database_id","subj":"306","obj":"Gene:3569"},{"id":"A329","pred":"tao:has_database_id","subj":"329","obj":"MESH:C000597346"},{"subj":"306","pred":"source","obj":"LitCovid-PubTator"},{"subj":"329","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T83","span":{"begin":0,"end":114},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T83","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#ec93c0","default":true},{"id":"LitCovid-sentences","color":"#93daec"}]}]}}